LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

UNH

389.29

-0.09%↓

AZN

184.71

+0.4%↑

Home・Lista de Ações・Cytek Biosciences Inc

Cytek Biosciences Inc

Fechado

SetorSaúde

3.57 0.28

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.45

Máximo

3.6

Indicadores-chave
By Trading Economics
Rendimento	25M -19M
Vendas	-18M 44M
EPS	-0.096
Margem de lucro	-42.746
Funcionários	678
EBITDA	-15M -16M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+57.06% upside

Dividendos
By Dow Jones
Próximos Ganhos	5 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-70M 532M
Abertura anterior	3.29
Fecho anterior	3.57

Sentimento de Notícias

By Acuity

50%

174 / 345 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

3.7 / 3.8 Suporte e Resistência

Cytek Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de mai. de 2026, 20:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19 de mai. de 2026, 23:28 UTC

Conversa de Mercado

Ganhos

Global Forex and Fixed Income Roundup: Market Talk

19 de mai. de 2026, 23:28 UTC

Conversa de Mercado

Ganhos

F&P Healthcare's Outlook Key for Investors -- Market Talk

19 de mai. de 2026, 23:10 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

19 de mai. de 2026, 23:10 UTC

Conversa de Mercado

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19 de mai. de 2026, 22:02 UTC

Ganhos

ZTO Express (Cayman): Di Xu to Resign From Board

19 de mai. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19 de mai. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19 de mai. de 2026, 22:00 UTC

Ganhos

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19 de mai. de 2026, 21:37 UTC

Ganhos

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19 de mai. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19 de mai. de 2026, 21:01 UTC

Ganhos

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19 de mai. de 2026, 20:58 UTC

Ganhos

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19 de mai. de 2026, 20:46 UTC

Ações em Alta

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19 de mai. de 2026, 20:43 UTC

Conversa de Mercado

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19 de mai. de 2026, 20:34 UTC

Ganhos

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19 de mai. de 2026, 20:32 UTC

Ganhos

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19 de mai. de 2026, 20:32 UTC

Ganhos

James Hardie Industries 4Q EPS 5c >JHX

19 de mai. de 2026, 20:32 UTC

Ganhos

James Hardie Industries 4Q Sales $1.4B >JHX

19 de mai. de 2026, 20:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices to Buy Empower Semiconductor for $1.5B

19 de mai. de 2026, 20:18 UTC

Conversa de Mercado

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19 de mai. de 2026, 20:13 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de mai. de 2026, 20:13 UTC

Conversa de Mercado

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19 de mai. de 2026, 20:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19 de mai. de 2026, 20:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19 de mai. de 2026, 20:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19 de mai. de 2026, 20:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19 de mai. de 2026, 19:23 UTC

Conversa de Mercado

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Comparação entre Pares

Variação de preço

Cytek Biosciences Inc Previsão

Preço-alvo

By TipRanks

57.06% parte superior

Previsão para 12 meses

Média 5.34 USD 57.06%

Máximo 7.5 USD

Mínimo 4.12 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Cytek Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para Cytek Biosciences Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

3.7 / 3.8Suporte e Resistência

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentimento

By Acuity

174 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.